Nome Químico: (2S,3S,4S,5R,6S)-2-(2-(4-Ethoxybenzyl)-4-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Sorrisos: O[C@@H]1[C@H](C2=CC=C([C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C2CC4=CC=C(OCC)C=C4)O[C@@H](CO)[C@H](O)[C@H]1O
Inchi: InChI=1S/C29H41N3O2.H2O4S/c1-4-19-17-31-12-9-21(19)14-27(31)29(33,28-15-22-10-13-32(28)18-20(22)5-2)25-8-11-30-26-7-6-23(34-3)16-24(25)26;1-5(2,3)4/h6-8,11,16,19-22,27-28,33H,4-5,9-10,12-15,17-18H2,1-3H3;(H2,1,2,3,4)/t19-,20-,21-,22-,27-,28-;/m0./s1
Stability indicating rp-hplc method for simultaneous estimation of dapagliflozin and saxagliptin in pharmaceutical dosage forms
By Thota, Hanisha; Soundarya, G.
From Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9131-9137
Method development and validation of a stability-indicating reversed-phase liquid chromatographic method for the simultaneous estimation of metformin and dapagliflozin in presence of their degradation products
By Kotecha, Nidhi; Patel, Jayvadan
From International Journal of Pharmaceutical Sciences Review and Research (2019), 56(2), 1-6.
Validation of a newly developed stability indicating RP-liquid chromatographic method for the quantitative determination of dapagliflozin
By Sura, Sreenivasulu; Modalavalasa, Rameswara Rao; Kothapalli, ChandraSekhar B.
From Pharma Chemica (2018), 10(1), 93-102